Transforming Discovery into Opportunity

CDRD provides a critical bridge between science and business – providing leading-edge academic discoveries with a path toward commercialization.

CDRD’s headquarters in the University of British Columbia’s Pharmaceutical Sciences Building includes 35,000 sq ft of state-of-the-art drug development infrastructure and translational research space.

UBC Pharmaceutical Sciences Building, home of The Centre for Drug Research and Development and CDRD Ventures Inc.

“GSK is proud to be working in collaboration with CDRD and CDRD Ventures Inc. Unique collaborations of this nature provide a highly effective way of progressing and commercializing the innovative health research conducted at Canadian public institutions…”
- Dr. Rav Kumar, Vice-President, Regulatory Affairs, GlaxoSmithKline

CDRD BY THE NUMBERS:

  • Over 125 projects undertaken
  • 47 technologies advanced toward commercialization and/or commercialized
  • 4 Spin-Off Companies
  • 3 Out-Licenses
  • 3 Under Current Development / Management of CVI

“”My transition from a postdoctoral fellow to an associate scientist position truly exemplifies CDRD’s mandate to train and develop the next generation of highly qualified young professionals in drug development research.”
- Dr.Pauline So, Associate Scientist, Target Validation

Our latest Trainee Spotlight focuses on Dr. Céline Hodler, our current Post-Doctoral Fellow in our Pharmacology/Toxicology Division.  Click here to find out more about Céline’s achievements.

“We’ve brought on a number of graduates of the CDRD Training Program as full-time permanent employees here at STEMCELL. They are by far the most industry-prepared of all our new recruits.”
- Dr. Allen Eaves, President and CEO, STEMCELL Technologies Inc.

CDRD de-risks promising discoveries stemming from publicly-funded health research and transform them into commercially viable opportunities for the private sector.

CDRD represents a tremendous opportunity to translate early research discoveries into technologies that are investable by the private sector, ultimately leading to new therapies for patients.

What is CDRD?

The Centre for Drug Research and Development (CDRD) is Canada’s fully-integrated national drug development and commercialization centre, providing expertise and infrastructure to enable researchers from leading health research institutions to advance promising early-stage drug candidates. Our mandate is to de-risk discoveries stemming from publicly-funded health research and transform them into viable investment opportunities for the private sector — thus successfully bridging the commercialization gap between academia and industry, and translating research discoveries into new therapies for patients. Canada’s Networks of Centres of Excellence Program has recognized CDRD as a Centre of Excellence for Commercialization and Research (CECR).

+ LEARN MORE

Latest from the Blog

The Immunotherapy Advantage….

Antipsychotics Against Schizophrenia: A Drug Pipeline That’s Running Dry?

+ VISIT THE BLOG

Latest from Twitter


+ FOLLOW US ON TWITTER



A Shared Vision










  • Industry
  • Academia
  • Government

Sign up to our newsletter

Receive CDRD’s and CVI's quarterly e-newsletter, The CDRD Pipeline and other e-communications for regular updates on all our news and activities.



© Copyright 2014 CDRD. All rights reserved.